Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Attolico, I.
20  Ergebnisse:
Personensuche X
?
1

P1319: T AND B LYMPHOCYTES SUBSETS AFTER BNT162B2 ANTI-SARS..:

Attolico, I. ; Tarantini, F. ; Schifone, C. P....
HemaSphere.  6 (2022)  - p. 1204-1205 , 2022
Link: https://doi.org/10.1097/..
 
?
2

Determinants of frontline tyrosine kinase inhibitor choice ..:

Tiribelli M ; Latagliata R ; Breccia M...
info:eu-repo/semantics/altIdentifier/pmid/37354090.  , 2023
Link: https://hdl.handle.net/1..
 
?
3

P1319: T AND B LYMPHOCYTES SUBSETS AFTER BNT162B2 ANTI-SARS..:

Attolico, I ; Tarantini, F ; Schifone, C. P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431018/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

COVID-19 infection in chronic myeloid leukaemia after one y..:

Breccia M ; Abruzzese E ; Accurso V...
info:eu-repo/semantics/altIdentifier/pmid/34636033.  , 2022
Link: http://hdl.handle.net/11..
 
?
5

Letermovir Prophylaxis for Cytomegalovirus Infection in All..:

Martino M ; Pitino A ; Gori M...
info:eu-repo/semantics/altIdentifier/pmid/34616684.  , 2021
Link: http://hdl.handle.net/23..
 
?
6

Low low-density lipoprotein (LDL), cholesterol and triglyce..:

Caocci G ; Mulas O ; Capodanno I...
info:eu-repo/semantics/altIdentifier/wos/WOS:000539139300001.  , 2020
Link: http://hdl.handle.net/11..
 
?
7

Low low-density lipoprotein (LDL), cholesterol and triglyce..:

Caocci G ; Mulas O ; Capodanno I...
info:eu-repo/semantics/altIdentifier/pmid/32514110.  , 2020
Link: http://hdl.handle.net/24..
 
?
8

Low-dose ponatinib is a good option in chronic myeloid leuk..:

Iurlo A ; Cattaneo D ; Malato A...
info:eu-repo/semantics/altIdentifier/pmid/32557788.  , 2020
Link: http://hdl.handle.net/24..
 
?
9

Low low-density lipoprotein (LDL), cholesterol and triglyce..:

Caocci G ; Mulas O ; Capodanno I...
info:eu-repo/semantics/altIdentifier/pmid/32514110.  , 2020
Link: http://hdl.handle.net/11..
 
?
10

Arterial occlusive events in chronic myeloid leukemia patie..:

Caocci G ; Mulas O ; Abruzzese E...
info:eu-repo/semantics/altIdentifier/pmid/30892724.  , 2019
Link: http://hdl.handle.net/24..
 
?
11

Skin lesions in chronic myeloid leukemia patients during da..:

Tarantini F ; Anelli L ; Ingravallo G...
info:eu-repo/semantics/altIdentifier/pmid/31692557.  , 2019
Link: http://hdl.handle.net/11..
 
?
12

Skin lesions in chronic myeloid leukemia patients during da..:

Tarantini F ; Anelli L ; Ingravallo G...
https://www.dovepress.com/skin-lesions-in-chronic-myeloid-leukemia-patients-during-dasatinib-tre-peer-reviewed-article-CMAR.  , 2019
Link: https://doaj.org/article..
 
?
13

Arterial occlusive events in chronic myeloid leukemia patie..:

Caocci G ; Mulas O ; Abruzzese E...
info:eu-repo/semantics/altIdentifier/pmid/30892724.  , 2019
Link: http://hdl.handle.net/11..
 
?
14

Predicting failure of hematopoietic stem cell mobilization ..:

Olivieri J ; Attolico I ; Nuccorini R...
info:eu-repo/semantics/altIdentifier/pmid/29330395.  , 2018
Link: http://hdl.handle.net/11..
 
?
15

Efficacy and tolerability of bendamustine, bortezomib and d..:

Offidani, M ; Corvatta, L ; Maracci, L...
info:eu-repo/semantics/altIdentifier/pmid/24270324.  , 2013
Link: http://hdl.handle.net/11..
 
1-15